RIGL Related Analyst Ratings
-
RBC Upgrades Rigel Pharmaceuticals (RIGL) to Outperform
-
Citi Downgrades Rigel Pharmaceuticals (RIGL) to Hold
-
Boenning & Scattergood Upgrades Rigel Pharmaceuticals (RIGL) to Outperform
-
Rodman & Renshaw Starts Rigel Pharma (RIGL) at Market Outperform, Multi-Billion Drug Potential
-
Barclays Gets Bullish On US Biotechnology Sector (BBH)
-
RBC Upgrades Rigel Pharmaceuticals (RIGL) to Sector Perform
-
RBC Capital Downgrades Rigel Pharmaceuticals (RIGL) to Underperform
-
Collins Stewart Initiates Coverage on Rigel Pharmaceuticals (RIGL) with a Hold
-
Susquehanna Reiterates a Positive on Rigel Pharmaceuticals (RIGL), Lowers Price Target
-
RBC Downgrades Rigel Pharma (RIGL) to Sector Perform
-
Susquehanna Initiates Coverage on Rigel Pharmaceuticals (RIGL) with a Positive
-
Piper Jaffray Initiates Coverage on Rigel Pharmaceuticals (RIGL) with a Buy
-
RBC Capital Initiates Coverage on Rigel Pharmaceuticals (RIGL) with an Outperform
-
Citi Initiates Coverage on Rigel (RIGL) with a Buy
-
Stanford Group Initiates Coverage on Rigel Pharmaceuticals (RIGL) with a Buy
-
Lehman Bros. Upgrades Rigel Pharmaceuticals (RIGL) to Overweight
-
CIBC Starts Rigel Pharmaceuticals (RIGL) with a Sector Outperformer
-
Credit Suisse Starts Rigel Pharms (RIGL) at Outperform
-
Jefferies & Co Initiates Coverage on Rigel Pharmaceuticals (RIGL) with a Buy
-
Needham Highlights Biotech Companies Presenting at the Upcoming American Society of Hematology
-
CSFB downgrades RIGL to Neutral
-
Wachovia Starts RIGL at Outperform
-
JMP Securities Started RIGL at Market Outperform
Back to RIGL Stock Lookup
